ambrisentan [Supplementary Concept]
an ET(A) receptor antagonist and antihypertensive agent; studied for use in pulmonary arterial hypertension
Date introduced: November 15, 2002
MeSH Unique ID: C467894
Registry Number: HW6NV07QEC
Heading Mapped to:
Entry Terms:
- (S)-ambrisentan
- (+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
- (+)-ambrisentan
- LU 208075
- LU-208075
- LU208075
- BSF 208075
- BSF-208075
- BSF208075
- Volibris
- ambrisentan, (-)-
- (R)-ambrisentan
- ambrisentan, (R)-
- (-)-ambrisentan
- GSK-1325760
- GSK 1325760A
- GSK1325760A
- GSK 1325760
- GSK-1325760A
- GSK1325760
- Letairis
- ambrisentan, (+-)-
- (+-)-ambrisentan
Pharmacologic Action: